Fred Aslan serves as Executive at Artiva Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Fred Aslan has executed 9 insider transactions totaling $263.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2025 involved selling 3,187 shares valued at $19.1K.
Fred Aslan currently holds 1,209,948 shares of Artiva Biotherapeutics, Inc. (ARTV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fred Aslan has been a net seller of ARTV stock. They have purchased $0 and sold $263.3K worth of shares.
Fred Aslan's most recent insider trade was on Dec 15, 2025, when they sold 3,187 shares at $6.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 17, 2025 | ARTV | $21.5K | Sale | 6,375 | $3.38 | Discretionary |
| Nov 15, 2025 | ARTV | $20.6K | Payment | 6,347 | $3.25 | Discretionary |
| Oct 17, 2025 | ARTV | $153.0K | Sale | 25,500 | $6.00 | Discretionary |
| Aug 15, 2025 | ARTV | $12.3K | Payment | 4,472 | $2.75 | Discretionary |
| Aug 15, 2025 | ARTV | $69.6K | Sale | 25,500 | $2.73 | Discretionary |
| May 15, 2025 | ARTV | $9.5K | Payment | 4,472 | $2.13 | Discretionary |
| Jul 22, 2024 | ARTV | $0 | Award | 228,905 | $N/A | Discretionary |